Clinical Trial Update: Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19 [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating antithrombin as a preventive therapy for acute respiratory distress syndrome in hospitalized COVID-19 patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Antithrombin (antithrombin)

Snippet

Sponsor: Maimónides Biomedical Research Institute of Córdoba | Conditions: Covid19, Severe Acute Respiratory Syndrome | Phase 2 | Status: COMPLETED